Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hematopoietic stem cell transplantation
Phenotype C0026986|myelodysplastic syndrome
Sentences 4
PubMedID- 26147089 Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: experience of the argentinean group of bone marrow transplantation (gatmo).
PubMedID- 26497198 Background: this report focuses on the adaptive phase i trial design aimed to find the clinically applicable dose for decitabine maintenance treatment after allogeneic hematopoietic stem cell transplantation in patients with higher-risk myelodysplastic syndrome and secondary acute myeloid leukemia.
PubMedID- 23113470 Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes.
PubMedID- 25778887 Objective: to evaluate the efficacy of decitabine (dac) bridging therapy followed by allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with myelodysplastic syndrome (mds).

Page: 1